Sp288
WHAT IS THE THIRD SPACE ANYWAY?
Date
May 6, 2023
Explore related products in the following collection:
Tracks
Related Products
OUTCOMES OF SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTION FOR SUBEPITHELIAL TUMORS IN THE UPPER GASTROINTESTINAL TRACT: EXPERIENCE FROM THE UNITED STATES
BACKGROUND: G-POEM has emerged as a treatment for medically refractory gastroparesis. Safe and effective mucosal closure is necessary to avoid potential morbidity…
OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR PREVIOUSLY ATTEMPTED COLORECTAL LESIONS: AN INTERNATIONAL MULTICENTER EXPERIENCE
BACKGROUND: The most common complication after endoscopic mucosal resection (EMR) is delayed bleeding (DB), especially in the proximal colon…
RATES OF RECURRENT INTESTINAL METAPLASIA AND DYSPLASIA AFTER SUCCESSFUL ENDOSCOPIC THERAPY OF BARRETT'S NEOPLASIA BY CAP ASSISTED EMR VS ESD AND ABLATION: RESULTS FROM A LARGE NORTH AMERICAN MULICENTER COHORT
Focal cryoballoon ablation (FCBA) is a relatively new ablation modality for the treatment of Barrett’s esophagus (BE) related neoplasia. This prospective, European multicenter study (Euro-Coldplay, NTR NL7253) aimed to evaluate the efficacy and safety of FCBA for the treatment of limited BE…
JOURNEY TO COMPLETE REMISSION OF DYSPLASIA AND INTESTINAL METAPLASIA AFTER ENDOSCOPIC ERADICATION THERAPY OF BARRETT’S ESOPHAGUS RELATED DYSPLASIA AND ADENOCARCINOMA: A COMPARATIVE ANALYSIS OF ESD VS EMR RESULTS FROM A MULTICENTER NORTH AMERICAN COHORT
Focal cryoballoon ablation (FCBA) is a relatively new ablation modality for the treatment of Barrett’s esophagus (BE) related neoplasia. This prospective, European multicenter study (Euro-Coldplay, NTR NL7253) aimed to evaluate the efficacy and safety of FCBA for the treatment of limited BE…